Systems announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit to moving to Veeva Vault CRM.

"Physicians have limited time and don't need repetitive information. The transfer must be efficient, with scientifically ...

Baird raised the firm’s price target on Veeva (VEEV) to $275 from $274 and keeps an Outperform rating on the shares. The firm updated its model following its Investor Day and admitted its mid-term ...

Veeva Systems (VEEV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

In the latest market close, Veeva Systems (VEEV) reached $217.73, with a -0.83% movement compared to the previous day. This change was narrower than the S&P 500's 0.92% loss on the day.

The most recent trading session ended with Veeva Systems (VEEV) standing at $217.02, reflecting a -0.14% shift from the previouse trading day's closing. The stock fell short of the S&P 500 ...

Top biopharma company selects the next generation of CRM for life sciences as its commercial foundation for future expansion and launches BARCELONA, Spain, Nov. 14, 2024 /PRNewswire/ -- Veeva Systems ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...